{"entity":{"type":"insider","cik":"0001433316","url":"/insider/0001433316","json_url":"/insider/0001433316.json","name":"Francis Knuettel II","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":8,"n_filings":5,"first":"2008-05-28","last":"2026-05-26","span_basis":"filed_date"},"name_variants":[{"name":"Francis Knuettel II","source":"filing","n_filings":5,"first_seen":"2008-05-28","last_seen":"2026-05-26"}],"transactions":[{"id":5759739,"accession":"0001919246-26-000081","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001919246-26-000081","line_url":"/filing/0001919246-26-000081#line-2","is_derivative":false,"issuer_cik":"0001433316","issuer_name":"Pelthos Therapeutics Inc.","issuer_ticker":"PTHS","issuer_name_source":null,"issuer_url":"/issuer/0001433316","owner_cik":"0001433316","owner_name":"Francis Knuettel II","owner_display_name":"Francis Knuettel II","owner_url":"/insider/0001433316","role":"Officer (CFO, Treas & Secty)","role_mark":"O","role_mark_label":"Officer (CFO, Treas & Secty)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO, Treas & Secty","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":26.8433,"price_display":"26.84","price_state":"stated","total_value":40264.95,"total_display":"40,264.95","total_whole":"40,265","shares_owned_after":11316.0,"shares_owned_after_display":"11,316","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-05-22","filed_date":"2026-05-26","scope":"insider"},{"id":3063353,"accession":"0001753926-24-001576","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001753926-24-001576","line_url":"/filing/0001753926-24-001576#line-2","is_derivative":false,"issuer_cik":"0001433316","issuer_name":"Chromocell Therapeutics Corp","issuer_ticker":"CHRO","issuer_name_source":null,"issuer_url":"/issuer/0001433316","owner_cik":"0001433316","owner_name":"Francis Knuettel II","owner_display_name":"Francis Knuettel II","owner_url":"/insider/0001433316","role":"Officer (CEO, Pres., CFO, Treas & Secty)","role_mark":"O","role_mark_label":"Officer (CEO, Pres., CFO, Treas & Secty)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO, Pres., CFO, Treas & Secty","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3500.0,"shares_display":"3,500","price_per_share":0.97,"price_display":"0.97","price_state":"stated","total_value":3395.0,"total_display":"3,395.00","total_whole":"3,395","shares_owned_after":547710.0,"shares_owned_after_display":"547,710","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-09-13","filed_date":"2024-09-16","scope":"insider"},{"id":3063350,"accession":"0001753926-24-001576","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001753926-24-001576","line_url":"/filing/0001753926-24-001576#line-1","is_derivative":false,"issuer_cik":"0001433316","issuer_name":"Chromocell Therapeutics Corp","issuer_ticker":"CHRO","issuer_name_source":null,"issuer_url":"/issuer/0001433316","owner_cik":"0001433316","owner_name":"Francis Knuettel II","owner_display_name":"Francis Knuettel II","owner_url":"/insider/0001433316","role":"Officer (CEO, Pres., CFO, Treas & Secty)","role_mark":"O","role_mark_label":"Officer (CEO, Pres., CFO, Treas & Secty)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO, Pres., CFO, Treas & Secty","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1700.0,"shares_display":"1,700","price_per_share":0.97,"price_display":"0.97","price_state":"stated","total_value":1649.0,"total_display":"1,649.00","total_whole":"1,649","shares_owned_after":544210.0,"shares_owned_after_display":"544,210","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-09-12","filed_date":"2024-09-16","scope":"insider"},{"id":2523669,"accession":"0001753926-24-001570","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001753926-24-001570","line_url":"/filing/0001753926-24-001570#line-2","is_derivative":false,"issuer_cik":"0001433316","issuer_name":"Chromocell Therapeutics Corp","issuer_ticker":"CHRO","issuer_name_source":null,"issuer_url":"/issuer/0001433316","owner_cik":"0001433316","owner_name":"Francis Knuettel II","owner_display_name":"Francis Knuettel II","owner_url":"/insider/0001433316","role":"Officer (CEO, Pres., CFO, Treas & Secty)","role_mark":"O","role_mark_label":"Officer (CEO, Pres., CFO, Treas & Secty)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO, Pres., CFO, Treas & Secty","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5500.0,"shares_display":"5,500","price_per_share":0.94,"price_display":"0.94","price_state":"stated","total_value":5170.0,"total_display":"5,170.00","total_whole":"5,170","shares_owned_after":542510.0,"shares_owned_after_display":"542,510","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-09-11","filed_date":"2024-09-12","scope":"insider"},{"id":2523664,"accession":"0001753926-24-001570","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001753926-24-001570","line_url":"/filing/0001753926-24-001570#line-1","is_derivative":false,"issuer_cik":"0001433316","issuer_name":"Chromocell Therapeutics Corp","issuer_ticker":"CHRO","issuer_name_source":null,"issuer_url":"/issuer/0001433316","owner_cik":"0001433316","owner_name":"Francis Knuettel II","owner_display_name":"Francis Knuettel II","owner_url":"/insider/0001433316","role":"Officer (CEO, Pres., CFO, Treas & Secty)","role_mark":"O","role_mark_label":"Officer (CEO, Pres., CFO, Treas & Secty)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO, Pres., CFO, Treas & Secty","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6500.0,"shares_display":"6,500","price_per_share":0.89,"price_display":"0.89","price_state":"stated","total_value":5785.0,"total_display":"5,785.00","total_whole":"5,785","shares_owned_after":537010.0,"shares_owned_after_display":"537,010","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-09-10","filed_date":"2024-09-12","scope":"insider"},{"id":6764471,"accession":"0001209191-18-038408","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-038408","line_url":"/filing/0001209191-18-038408#line-2","is_derivative":false,"issuer_cik":"0001433316","issuer_name":"Aqua Metals, Inc.","issuer_ticker":"AQMS","issuer_name_source":null,"issuer_url":"/issuer/0001433316","owner_cik":"0001433316","owner_name":"Francis Knuettel II","owner_display_name":"Francis Knuettel II","owner_url":"/insider/0001433316","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":2.85,"price_display":"2.85","price_state":"stated","total_value":14250.0,"total_display":"14,250.00","total_whole":"14,250","shares_owned_after":162500.0,"shares_owned_after_display":"162,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-18","filed_date":"2018-06-18","scope":"insider"},{"id":6764469,"accession":"0001209191-18-038408","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-038408","line_url":"/filing/0001209191-18-038408#line-1","is_derivative":false,"issuer_cik":"0001433316","issuer_name":"Aqua Metals, Inc.","issuer_ticker":"AQMS","issuer_name_source":null,"issuer_url":"/issuer/0001433316","owner_cik":"0001433316","owner_name":"Francis Knuettel II","owner_display_name":"Francis Knuettel II","owner_url":"/insider/0001433316","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":3.3366,"price_display":"3.34","price_state":"stated","total_value":8341.5,"total_display":"8,341.50","total_whole":"8,342","shares_owned_after":157500.0,"shares_owned_after_display":"157,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-15","filed_date":"2018-06-18","scope":"insider"},{"id":3286461,"accession":"0001140361-08-013797","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-08-013797","line_url":"/filing/0001140361-08-013797#line-1","is_derivative":false,"issuer_cik":"0001012316","issuer_name":"Firepond, Inc.","issuer_ticker":"FPND.OB","issuer_name_source":null,"issuer_url":"/issuer/0001012316","owner_cik":"0001433316","owner_name":"Francis Knuettel II","owner_display_name":"Francis Knuettel II","owner_url":"/insider/0001433316","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":0.6,"price_display":"0.60","price_state":"stated","total_value":1500.0,"total_display":"1,500.00","total_whole":"1,500","shares_owned_after":210887.0,"shares_owned_after_display":"210,887","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-05-27","filed_date":"2008-05-28","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":8,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":7,"open_market":true},{"code":"S","label":"Open-market sale","n":1,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":8},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001919246","name":"Pelthos Therapeutics Inc.","url":"/issuer/0001919246","role":"Officer (CFO, Treas & Secty)","n_filings":3,"first_seen":"2024-09-12","last_seen":"2026-05-26"},{"type":"issuer","type_label":"ISSUER","cik":"0001621832","name":"Aqua Metals, Inc.","url":"/issuer/0001621832","role":"Officer (Chief Financial Officer)","n_filings":1,"first_seen":"2018-06-18","last_seen":"2018-06-18"},{"type":"issuer","type_label":"ISSUER","cik":"0001012316","name":"Firepond, Inc.","url":"/issuer/0001012316","role":"Director","n_filings":1,"first_seen":"2008-05-28","last_seen":"2008-05-28"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001433316","retrieved_at":"2026-08-27T07:56:23+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}